Adempas
Active substance: riociguat
TABLET, FILM COATED · RIOCIGUAT .5 mg/1
United StatesActive
Marketing holder: Bayer HealthCare Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RIOCIGUAT · .5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-6c44-7dcb-8286-c1b78f66734b,01a1208c-bb76-7179-9a6c-57f6a2816fe0,01a1208e-e150-72fc-9a54-646c55b1bdbd,01a12092-8518-7184-91a0-a04c15929efe,01a12093-9736-77ec-b5be-7493bc30a37c;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50419-250
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 50419-250 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50419-250 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50419-250 · Verified 2026-10-09 · open in source